AbbVie Inc. SEC filings ABBV
AbbVie Inc. has 1,006 filings in SEC EDGAR's recent list, going back to May 9, 2017. Its latest annual report, Form ARS, was filed on Mar 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 3, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Officer or director change
|
Nov 2, 2026 | Oct 28, 2026 |
| 8-K |
Current report
Results of operations
|
Oct 30, 2026 | Oct 30, 2026 |
| 8-K |
Current report
Officer or director change
|
Oct 15, 2026 | Oct 14, 2026 |
| 8-K |
Current report
Results of operations
|
Oct 5, 2026 | Oct 5, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 3, 2026 | Sep 3, 2026 |
| 8-K |
Current report
Other events
|
Aug 18, 2026 | Aug 18, 2026 |
| 424B5 | Prospectus supplement | Aug 6, 2026 | — |
| 8-K |
Current report
Other events
|
Aug 5, 2026 | Aug 4, 2026 |
| FWP | Free writing prospectus | Aug 5, 2026 | — |
| 424B5 | Prospectus supplement | Aug 4, 2026 | — |
| 10-Q | Quarterly report | Aug 3, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Jul 31, 2026 | Jul 31, 2026 |
| 8-K |
Current report
Results of operations
|
Jul 6, 2026 | Jul 6, 2026 |
| 11-K | Employee savings plan report | Jun 24, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 22, 2026 | Jun 18, 2026 |
| SD | Specialized disclosure (conflict minerals) | Jun 1, 2026 | — |
| 8-K |
Current report
Shareholder vote results
|
May 12, 2026 | May 8, 2026 |
| 10-Q | Quarterly report | May 8, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
Apr 29, 2026 | Apr 29, 2026 |
| 8-K |
Current report
Results of operations
|
Apr 3, 2026 | Apr 3, 2026 |
| ARS | Annual report to shareholders | Mar 23, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Mar 23, 2026 | — |
| DEF 14A | Proxy statement | Mar 23, 2026 | May 8, 2026 |
| PRE 14A | Preliminary proxy statement | Mar 9, 2026 | Mar 9, 2026 |
| 8-K |
Current report
Other events
|
Mar 4, 2026 | Mar 4, 2026 |
| 8-K |
Current report
Other events
|
Feb 26, 2026 | Feb 24, 2026 |
| 424B5 | Prospectus supplement | Feb 26, 2026 | — |
| FWP | Free writing prospectus | Feb 26, 2026 | — |
| FWP | Free writing prospectus | Feb 25, 2026 | — |
| 424B5 | Prospectus supplement | Feb 24, 2026 | — |
| 10-K | Annual report | Feb 20, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 4, 2026 | Feb 4, 2026 |
| 8-K |
Current report
Results of operations
|
Jan 7, 2026 | Jan 7, 2026 |
| 10-Q | Quarterly report | Nov 4, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Oct 31, 2025 | Oct 31, 2025 |
| 8-K |
Current report
Results of operations
|
Oct 3, 2025 | Oct 3, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 11, 2025 | Sep 11, 2025 |
| 10-Q | Quarterly report | Aug 4, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Jul 31, 2025 | Jul 31, 2025 |
| 8-K |
Current report
Results of operations
|
Jul 3, 2025 | Jul 3, 2025 |
| 11-K | Employee savings plan report | Jun 13, 2025 | Dec 31, 2024 |
| SD | Specialized disclosure (conflict minerals) | May 30, 2025 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 13, 2025 | May 8, 2025 |
| 10-Q | Quarterly report | May 9, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
Apr 25, 2025 | Apr 25, 2025 |
| 8-K |
Current report
Results of operations
|
Apr 3, 2025 | Apr 3, 2025 |
| ARS | Annual report to shareholders | Mar 25, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Mar 24, 2025 | — |
| DEF 14A | Proxy statement | Mar 24, 2025 | May 9, 2025 |
| PRE 14A | Preliminary proxy statement | Mar 10, 2025 | May 9, 2025 |
| 8-K |
Current report
Other events
|
Feb 26, 2025 | Feb 26, 2025 |
| 424B5 | Prospectus supplement | Feb 20, 2025 | — |
| 8-K |
Current report
Other events
|
Feb 19, 2025 | Feb 18, 2025 |
| FWP | Free writing prospectus | Feb 19, 2025 | — |
| 424B5 | Prospectus supplement | Feb 18, 2025 | — |
| S-3ASR | Automatic shelf registration | Feb 14, 2025 | — |
| 10-K | Annual report | Feb 14, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Feb 14, 2025 | Feb 13, 2025 |
| 8-K |
Current report
Other events
|
Feb 5, 2025 | Jan 30, 2025 |
| 8-K |
Current report
Results of operations
|
Jan 31, 2025 | Jan 31, 2025 |
| 8-K |
Current report
Impairment
|
Jan 10, 2025 | Jan 9, 2025 |
| 8-K |
Current report
Results of operations
|
Jan 6, 2025 | Jan 6, 2025 |
| 8-K |
Current report
Officer or director change
|
Dec 13, 2024 | Dec 11, 2024 |
| S-8 | Employee stock plan registration | Nov 4, 2024 | — |
| S-8 | Employee stock plan registration | Nov 4, 2024 | — |
| 10-Q | Quarterly report | Nov 4, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Oct 30, 2024 | Oct 30, 2024 |
| 8-K |
Current report
Results of operations
|
Oct 3, 2024 | Oct 3, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Sep 10, 2024 | Sep 6, 2024 |
| S-8 | Employee stock plan registration | Aug 14, 2024 | — |
| 10-Q | Quarterly report | Aug 7, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Jul 25, 2024 | Jul 25, 2024 |
| 8-K |
Current report
Results of operations
|
Jul 3, 2024 | Jul 3, 2024 |
| 11-K | Employee savings plan report | Jun 27, 2024 | Dec 31, 2023 |
| 25-NSE | Delisting notice | Jun 3, 2024 | — |
| SD | Specialized disclosure (conflict minerals) | May 31, 2024 | — |
| 25-NSE | Delisting notice | May 17, 2024 | — |
| 8-K/A |
Amended current report
Officer or director change, Shareholder vote results
|
May 8, 2024 | Feb 14, 2024 |
| 10-Q | Quarterly report | May 3, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
Apr 26, 2024 | Apr 26, 2024 |
| 8-K |
Current report
Results of operations
|
Apr 3, 2024 | Apr 3, 2024 |
| PX14A6G | Filing | Apr 2, 2024 | — |
| PX14A6G | Filing | Mar 26, 2024 | — |
| ARS | Annual report to shareholders | Mar 18, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Mar 18, 2024 | — |
| DEF 14A | Proxy statement | Mar 18, 2024 | May 3, 2024 |
| PRE 14A | Preliminary proxy statement | Mar 4, 2024 | May 3, 2024 |
| 8-K |
Current report
Other events
|
Feb 26, 2024 | Feb 22, 2024 |
| 424B5 | Prospectus supplement | Feb 26, 2024 | — |
| FWP | Free writing prospectus | Feb 23, 2024 | — |
| S-8 | Employee stock plan registration | Feb 23, 2024 | — |
| 424B5 | Prospectus supplement | Feb 21, 2024 | — |
| 10-K | Annual report | Feb 20, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Feb 20, 2024 | Feb 14, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 12, 2024 | Feb 12, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 2, 2024 | Feb 2, 2024 |
| 8-K |
Current report
Results of operations
|
Jan 5, 2024 | Jan 5, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 6, 2023 | Dec 6, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 30, 2023 | Nov 30, 2023 |
| 25-NSE | Delisting notice | Nov 15, 2023 | — |
| 10-Q | Quarterly report | Nov 6, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Oct 27, 2023 | Oct 27, 2023 |
| 8-K |
Current report
Officer or director change
|
Oct 12, 2023 | Oct 11, 2023 |
| 8-K |
Current report
Results of operations
|
Oct 4, 2023 | Oct 4, 2023 |
| 10-Q | Quarterly report | Aug 7, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Jul 27, 2023 | Jul 27, 2023 |
| 8-K |
Current report
Results of operations
|
Jul 6, 2023 | Jul 6, 2023 |
| 8-K |
Current report
Officer or director change
|
Jun 29, 2023 | Jun 29, 2023 |
| 11-K | Employee savings plan report | Jun 28, 2023 | Dec 31, 2022 |
| S-8 POS | Filing | Jun 9, 2023 | — |
| SD | Specialized disclosure (conflict minerals) | May 31, 2023 | — |
| 8-K |
Current report
Shareholder vote results
|
May 10, 2023 | May 5, 2023 |
| 10-Q | Quarterly report | May 5, 2023 | Mar 31, 2023 |
| PX14A6G | Filing | May 4, 2023 | — |
| 8-K |
Current report
Results of operations
|
Apr 27, 2023 | Apr 27, 2023 |
| PX14A6G | Filing | Apr 20, 2023 | — |
| PX14A6G | Filing | Apr 11, 2023 | — |
| 8-K |
Current report
Results of operations
|
Apr 5, 2023 | Apr 5, 2023 |
| 8-K |
Current report
Material agreement, New debt
|
Mar 28, 2023 | Mar 28, 2023 |
| DEFA14A | Additional proxy material | Mar 28, 2023 | — |
| PX14A6G | Filing | Mar 28, 2023 | — |
| PX14A6G | Filing | Mar 28, 2023 | — |
| ARS | Annual report to shareholders | Mar 21, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Mar 21, 2023 | — |
| DEFA14A | Additional proxy material | Mar 20, 2023 | — |
| DEF 14A | Proxy statement | Mar 20, 2023 | — |
| PRE 14A | Preliminary proxy statement | Mar 6, 2023 | — |
| 10-K | Annual report | Feb 17, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Feb 9, 2023 | Feb 9, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 10, 2023 | Jan 10, 2023 |
| 8-K |
Current report
Results of operations
|
Jan 6, 2023 | Jan 6, 2023 |
| 8-K |
Current report
Officer or director change
|
Nov 29, 2022 | Nov 28, 2022 |
| S-8 | Employee stock plan registration | Nov 4, 2022 | — |
| 10-Q | Quarterly report | Nov 4, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Oct 28, 2022 | Oct 28, 2022 |
| UPLOAD | Letter from the SEC | Oct 20, 2022 | — |
| 8-K |
Current report
Officer or director change
|
Oct 17, 2022 | Oct 12, 2022 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change
|
Oct 14, 2022 | Oct 12, 2022 |
| 8-K |
Current report
Results of operations
|
Oct 5, 2022 | Oct 5, 2022 |
| CORRESP | Letter to the SEC | Oct 4, 2022 | — |
| UPLOAD | Letter from the SEC | Sep 20, 2022 | — |
| 10-Q | Quarterly report | Aug 4, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Jul 29, 2022 | Jul 29, 2022 |
| 8-K |
Current report
Results of operations
|
Jul 6, 2022 | Jul 6, 2022 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Jun 29, 2022 | Jun 23, 2022 |
| 8-K |
Current report
Officer or director change
|
Jun 28, 2022 | Jun 23, 2022 |
| 11-K | Employee savings plan report | Jun 23, 2022 | Dec 31, 2021 |
| 11-K | Employee savings plan report | Jun 23, 2022 | Dec 31, 2021 |
| SD | Specialized disclosure (conflict minerals) | May 31, 2022 | — |
| 8-K |
Current report
Shareholder vote results
|
May 11, 2022 | May 6, 2022 |
| 10-Q | Quarterly report | May 6, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
Apr 29, 2022 | Apr 29, 2022 |
| 8-K |
Current report
Results of operations
|
Apr 29, 2022 | Apr 29, 2022 |
| 8-K |
Current report
Results of operations
|
Apr 21, 2022 | Apr 21, 2022 |
| 8-K |
Current report
Officer or director change
|
Apr 13, 2022 | Apr 8, 2022 |
| PX14A6G | Filing | Apr 11, 2022 | — |
| PX14A6G | Filing | Apr 4, 2022 | — |
| PX14A6G | Filing | Mar 30, 2022 | — |
| PX14A6G | Filing | Mar 25, 2022 | — |
| DEFA14A | Additional proxy material | Mar 21, 2022 | — |
| DEF 14A | Proxy statement | Mar 21, 2022 | May 6, 2022 |
| PRE 14A | Preliminary proxy statement | Mar 7, 2022 | May 6, 2022 |
| 8-K |
Current report
Officer or director change
|
Mar 4, 2022 | Feb 28, 2022 |
| S-3ASR | Automatic shelf registration | Feb 22, 2022 | — |
| 10-K | Annual report | Feb 18, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Feb 2, 2022 | Feb 2, 2022 |
| 8-K |
Current report
Officer or director change
|
Dec 17, 2021 | Dec 16, 2021 |
| 8-K |
Current report
Officer or director change
|
Dec 16, 2021 | Dec 16, 2021 |
| 10-Q | Quarterly report | Nov 2, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations
|
Oct 29, 2021 | Oct 29, 2021 |
| 8-K |
Current report
Other events
|
Aug 19, 2021 | Aug 19, 2021 |
| 10-Q | Quarterly report | Aug 2, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations
|
Jul 30, 2021 | Jul 30, 2021 |
| 11-K | Employee savings plan report | Jun 21, 2021 | Dec 31, 2020 |
| 11-K | Employee savings plan report | Jun 21, 2021 | Dec 31, 2020 |
| SD | Specialized disclosure (conflict minerals) | Jun 1, 2021 | — |
| S-8 | Employee stock plan registration | May 12, 2021 | — |
| 8-K |
Current report
Shareholder vote results
|
May 10, 2021 | May 7, 2021 |
| 10-Q | Quarterly report | May 7, 2021 | Mar 31, 2021 |
| 25-NSE | Delisting notice | May 4, 2021 | — |
| UPLOAD | Letter from the SEC | May 4, 2021 | — |
| 8-K |
Current report
Results of operations
|
Apr 30, 2021 | Apr 30, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 20, 2021 | Apr 16, 2021 |
| PX14A6G | Filing | Apr 15, 2021 | — |
| PX14A6G | Filing | Mar 31, 2021 | — |
| PX14A6G | Filing | Mar 29, 2021 | — |
| DEFA14A | Additional proxy material | Mar 22, 2021 | — |
| DEF 14A | Proxy statement | Mar 22, 2021 | May 7, 2021 |
| CORRESP | Letter to the SEC | Mar 19, 2021 | — |
| UPLOAD | Letter from the SEC | Mar 16, 2021 | — |
| 8-K | Current report | Mar 12, 2021 | Mar 12, 2021 |
| PRE 14A | Preliminary proxy statement | Mar 8, 2021 | May 7, 2021 |
| 10-K | Annual report | Feb 19, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Results of operations
|
Feb 3, 2021 | Feb 3, 2021 |
| CORRESP | Letter to the SEC | Jan 15, 2021 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 12, 2021 | Jan 12, 2021 |
| 8-K |
Current report
Officer or director change
|
Jan 6, 2021 | Dec 31, 2020 |
| UPLOAD | Letter from the SEC | Dec 22, 2020 | — |
| CERT | Nyse certification | Nov 20, 2020 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ABBV (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- North Chicago, IL
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1551152
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
- Pfizer Inc PFE
Source: SEC EDGAR filings. This is company-reported data, not investment advice.